Ключевые слова
Аннотация
Non-alcoholic fatty liver disease is a widespread liver disorder that often progresses without noticeable symptoms, making early detection challenging. Traditional invasive diagnostic methods are uncomfortable for patients and have limited applicability. Non-invasive approaches using artificial intelligence provide accurate, rapid, and objective detection of fat accumulation in the liver. Stepwise evaluation of disease severity allows personalized treatment planning and effective monitoring of disease progression. AI-assisted diagnostics enhance patient safety, improve clinical efficiency, and support large-scale screening and research. This approach represents a significant advancement in the early detection and management of fatty liver disease.
Библиографические ссылки
Noureddin, M., Lam, J., Peterson, M., et al. (2019). Utility of artificial intelligence in imaging for NAFLD diagnosis. Hepatology Communications, 3(11), 1501–1512.
Ciardullo, S., Perseghin, G. (2021). Machine learning applications in non-alcoholic fatty liver disease. World Journal of Gastroenterology, 27(42), 7245–7260.
He, Y., et al. (2020). Non-invasive assessment of liver fat using deep learning algorithms. European Radiology, 30(7), 3832–3842.
Boursier, J., et al. (2016). Clinical applications of non-invasive imaging and AI in NAFLD. Journal of Hepatology, 65(3), 683–693.
Lo, J. C., et al. (2022). Integrating AI with MRI and ultrasound for NAFLD staging. Frontiers in Medicine, 9, 857642.
Zhang, Q., et al. (2021). AI-driven non-invasive biomarkers for NAFLD progression. Liver International, 41(5), 1020–1032.